Ambo Agritec Limited has scheduled a meeting of its Board of Directors for Monday, August 17, 2026, to discuss and review the company's growth and performance. The notice of the meeting was issued on August 11, 2026, in compliance with regulatory disclosure requirements.

The intimation was submitted to BSE Limited under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events, including the scheduling of board meetings, to ensure transparency for investors and stakeholders.

Meeting Details

The Board meeting is convened to assess the operational trajectory of the business. While the specific resolutions or financial outcomes are not detailed in the preliminary notice, the primary objective remains the evaluation of strategic growth metrics.

Umesh Kumar Agarwal, Managing Director (DIN: 00210217), signed the disclosure on behalf of the company. Ambo Agritec Limited, formerly known as Ambo Agritec Private Limited, is registered at Chandrakunj Building in Kolkata, West Bengal.

What the Numbers Show

As this is a preliminary notice of a board meeting rather than a financial results filing, no quantitative data such as revenue, profit, or EBITDA is available for analysis. The significance of this event lies in its procedural compliance with SEBI listing norms, ensuring that market participants are informed of upcoming corporate governance activities. Investors should monitor subsequent filings for any decisions or approvals resulting from this meeting.

Ambo Agritec Limited failed to file its financial results for the year ended March 31, 2026, within the timeline prescribed by Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The delay was caused by the sudden illness of the company's Chief Financial Officer, who plays a key role in finalizing, reviewing, and certifying the financial statements. The executive was suffering from high fever and cough and was medically advised to take complete bed rest for five days.

The unavailability of the CFO due to this medical condition led to an unavoidable postponement of the financial closing process, internal review, and coordination required to place the results before the Board of Directors. Consequently, the submission to the stock exchange was delayed. The company clarified that the delay was unintentional and resulted from circumstances beyond its control.

Ambo Agritec has since completed the necessary steps and filed the financial results at the earliest possible date. In a communication to BSE Limited, the company expressed regret for the delay and affirmed its commitment to ensuring full compliance with all applicable regulatory requirements.

To prevent future occurrences, the company stated that it is taking necessary steps to strengthen internal processes. The explanation was submitted to the exchange on June 22, 2026, by Umesh Kumar Agarwal, Managing Director of Ambo Agritec Limited.